Vasopressor SAT Study

Running, not enrolling

Conditions studied: Low Blood Pressure, Delirium, Critical Illness

In brief

To assess the impact of daily awakening from sedation on the amount of vasoactive medication required in the ICU. The hypothesis of this proposal is that the amount of vasoactive drug required to maintain an adequate mean arterial blood pressure will be reduced during a daily awakening from sedation.

Key facts

Study ID

NCT03182335

Run by

University of Chicago

People needed

800

Starts

2014-04-28

Expected to finish

2026-11-01

Last updated by the study team

2026-07-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• requiring Mechanical ventilation through an endotracheal tube with infusion of sedative or analgesic agent for comfort
• requiring vasoactive drug via central venous catheter for the treatment of shock

You may not qualify if…

• patients receiving Dexmedetomidine as sedative

Where it is running

• The University of Chicago Medical Center — Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.